Alison D. Schecter - Dec 10, 2021 Form 4 Insider Report for Axcella Health Inc. (AXLA)

Role
President - Research & Dev.
Signature
By: /s/ Paul Fehlner, Attorney-in-Fact
Stock symbol
AXLA
Transactions as of
Dec 10, 2021
Transactions value $
$0
Form type
4
Date filed
12/14/2021, 04:21 PM
Next filing
Feb 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Stock Option (Right to Buy) Award $0 +25K $0.00 25K Dec 10, 2021 Common Stock 25K $5.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 17, 2021, the Reporting Person was granted an option to purchase 75,000 shares of AXLA common stock, which vest in three equal installments subject to the satisfaction of certain performance criteria. On December 10, 2021, the Issuer's Compensation Committee confirmed that the performance criteria had been met with regards to one installment, resulting in the vesting of 25,000 shares.